Aetna 2013 Annual Report Download - page 133

Download and view the complete annual report

Please find page 133 of the 2013 Aetna annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 156

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156

Annual Report- Page 127
We issued approximately $700 million of commercial paper in 2013 to finance a portion of the cash purchase price
for the Coventry acquisition. At December 31, 2013 and 2012, we did not have any commercial paper outstanding.
We paid $364 million, $242 million and $254 million in interest in 2013, 2012 and 2011, respectively.
Long-Term Debt and Interest Rate Swaps
During June and July of 2012, we entered into two interest rate swaps with an aggregate notional value of $375
million. We designated these swaps as cash flow hedges against interest rate exposure related to the forecasted
future issuance of fixed-rate debt to refinance long-term debt maturing in June 2016. At December 31, 2013, these
interest rate swaps had a pretax fair value gain of $48.4 million, which was reflected net of tax in accumulated other
comprehensive loss within shareholders' equity.
In November 2012, we issued $500 million of 1.50% senior notes due 2017, $1.0 billion of 2.75% senior notes due
2022 and $500 million of 4.125% senior notes due 2042 (collectively, the “2012 Coventry-related senior notes”), in
connection with the acquisition of Coventry. In the period from August 2012 through October 2012, prior to issuing
the 2012 Coventry-related senior notes, we entered into 16 interest rate swaps with an aggregate notional value of
$2.0 billion and designated these swaps as cash flow hedges against interest rate exposure related to the forecasted
future issuance of that fixed-rate debt. We terminated the swaps prior to issuing the 2012 Coventry-related senior
notes and paid an aggregate of $4.8 million to the swap counterparties upon that termination. The related $4.8
million pretax loss is recorded in accumulated other comprehensive loss, net of tax, and is being amortized as an
increase to interest expense over the first 10, 20 and 60 semi-annual interest payments associated with the
respective 2012 Coventry-related senior notes.
In May 2012, we issued $250 million of 1.75% senior notes due 2017 and $500 million of 4.5% senior notes due
2042 (collectively, the “2012 Senior Notes”). In 2011, prior to issuing the 2012 Senior Notes, we entered into two
interest rate swaps with an aggregate notional value of $250 million and designated these swaps as cash flow
hedges against interest rate exposure related to the forecasted future issuance of fixed-rate debt. Prior to issuing the
2012 Senior Notes, we terminated the two interest rate swaps and paid an aggregate of $7.5 million to the swap
counterparties upon that termination. The related $7.5 million pretax loss is recorded in accumulated other
comprehensive loss, net of tax, and is being amortized as an increase to interest expense over the first 20 semi-
annual interest payments associated with the $500 million of 4.5% senior notes due 2042.
Revolving Credit Facility
On March 27, 2012, we entered into an unsecured $1.5 billion five-year revolving credit agreement (the “Credit
Agreement”) with several financial institutions. On September 24, 2012, in connection with the acquisition of
Coventry, we entered into a First Amendment (the “First Amendment”) to the Credit Agreement and also entered
into an Incremental Commitment Agreement (the “Incremental Commitment”, and together with the First
Amendment and the Credit Agreement, resulting in the “Facility”). The Facility is an unsecured $2.0 billion
revolving credit agreement. Upon our agreement with one or more financial institutions, we may expand the
aggregate commitments under the Facility to a maximum of $2.5 billion. The Facility also provides for the issuance
of up to $200 million of letters of credit at our request, which count as usage of the available commitments under
the Facility. On March 27, 2013, the maturity date of the Facility was extended by one year to March 27, 2018.
Various interest rate options are available under the Facility. Any revolving borrowings mature on the termination
date of the Facility. We pay facility fees on the Facility ranging from .070% to .150% per annum, depending upon
our long-term senior unsecured debt rating. The facility fee was .100% at December 31, 2013. The Facility
contains a financial covenant that requires us to maintain a ratio of total debt to consolidated capitalization as of the
end of each fiscal quarter at or below 50%. For this purpose, consolidated capitalization equals the sum of total
shareholders’ equity, excluding any overfunded or underfunded status of our pension and OPEB plans and any net
unrealized capital gains and losses, and total debt (as defined in the Facility). We met this requirement at
December 31, 2013. There were no amounts outstanding under the Facility, at any time during the year ended
December 31, 2013 or 2012.